Single-cell sequencing analysis and bulk-seq identify IGFBP6 and TNFAIP6 as novel differential diagnosis markers for postburn pathological scarring
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified two key genes, insulin-like growth factor binding protein 6 and tumor necrosis factor alpha-induced protein 6, to differentiate between keloids and hypertrophic scars. These molecular biomarkers offer improved diagnostic accuracy for postburn pathological scars.
Area Of Science
- Biomolecular analysis
- Dermatological research
- Single-cell genomics
Background
- Postburn pathological scars, including keloids and hypertrophic scars, necessitate accurate diagnosis for effective treatment.
- Current molecular-level differential diagnosis for these scars is limited.
- Single-cell sequencing offers a novel approach to investigate scar heterogeneity at the cellular level.
Purpose Of The Study
- To identify molecular diagnostic biomarkers for distinguishing between postburn keloids and hypertrophic scars.
- To leverage single-cell sequencing to uncover genetic differences between scar types.
- To establish a basis for improved differential diagnosis and targeted treatment strategies.
Main Methods
- Single-cell RNA sequencing was employed to analyze cellular composition and gene expression in keloids and hypertrophic scars.
- Differential gene expression analysis and weighted gene co-expression network analysis (WGCNA) were performed.
- Key candidate genes were validated using immunohistochemical staining and quantitative reverse transcription PCR on clinical samples.
Main Results
- Single-cell sequencing identified distinct cell clusters, primarily fibroblasts, in both keloid and hypertrophic scars.
- Differential gene expression analysis highlighted significant differences in gene expression profiles between the two scar types.
- Insulin-like growth factor binding protein 6 (IGFBP6) and tumor necrosis factor alpha-induced protein 6 (TNFAIP6) were identified as key discriminators, with IGFBP6 achieving 1.0 and TNFAIP6 achieving 0.75 diagnostic accuracy.
Conclusions
- TNFAIP6 and IGFBP6 demonstrate high diagnostic accuracy for differentiating postburn keloids from hypertrophic scars.
- These identified genes serve as valuable molecular biomarkers for clinical diagnosis.
- The findings provide crucial guidance for the differential diagnosis and treatment of pathological scars.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
